Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Selroos

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Treatments in Respiratory Medicine|August 25, 2006
Performance of Turbuhaler((R)) in Patients with Acute Airway Obstruction and COPD, and in Children with Asthma : Understanding the Clinical Importance of Adequate Peak Inspiratory Flow, High Lung Deposition, and Low In Vivo Dose VariabilityOlof Selroos, Lars Borgström, Jarl Ingelf
ERJ Open Research|October 13, 2016
Revisiting early intervention in adult asthmaTari Haahtela, Olof Selroos, Paul M O'Byrne
Ground Water|February 25, 2005
Upscaling of hydraulic conductivity and telescopic mesh refinementDouglas D Walker, Björn Gylling, Jan-Olof Selroos
Ambio|April 27, 2013
Identification and characterization of potential discharge areas for radionuclide transport by groundwater from a nuclear waste repository in SwedenSten Berglund, Emma Bosson, Jan-Olof Selroos, et al.
Chest|January 18, 2002
Early treatment of stage II sarcoidosis improves 5-year pulmonary functionAnne Pietinalho, Pentti Tukiainen, Tari Haahtela, et al.
Frontiers in Immunology|January 11, 2020
Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis PrognosisElisa Lahtela, Matti Kankainen, Juha Sinisalo, et al.
Respiratory Research|February 21, 2009
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre studyBjörn Ställberg, Olof Selroos, Claus Vogelmeier, et al.
Pulmonary Pharmacology & Therapeutics|October 24, 2007
Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?Staffan Edsbäcker, Per Wollmer, Olof Selroos, et al.
Drugs in R&D|September 18, 2013
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPDGabriella Gálffy, Györgyi Mezei, Gyula Németh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 3, 2016
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler dataVeronika Müller, Gabriella Gálffy, Márta Orosz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Treatments in Respiratory Medicine|August 25, 2006
Performance of Turbuhaler((R)) in Patients with Acute Airway Obstruction and COPD, and in Children with Asthma : Understanding the Clinical Importance of Adequate Peak Inspiratory Flow, High Lung Deposition, and Low In Vivo Dose VariabilityOlof Selroos, Lars Borgström, Jarl Ingelf
ERJ Open Research|October 13, 2016
Revisiting early intervention in adult asthmaTari Haahtela, Olof Selroos, Paul M O'Byrne
Ground Water|February 25, 2005
Upscaling of hydraulic conductivity and telescopic mesh refinementDouglas D Walker, Björn Gylling, Jan-Olof Selroos
Ambio|April 27, 2013
Identification and characterization of potential discharge areas for radionuclide transport by groundwater from a nuclear waste repository in SwedenSten Berglund, Emma Bosson, Jan-Olof Selroos, et al.
Chest|January 18, 2002
Early treatment of stage II sarcoidosis improves 5-year pulmonary functionAnne Pietinalho, Pentti Tukiainen, Tari Haahtela, et al.
Frontiers in Immunology|January 11, 2020
Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis PrognosisElisa Lahtela, Matti Kankainen, Juha Sinisalo, et al.
Respiratory Research|February 21, 2009
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre studyBjörn Ställberg, Olof Selroos, Claus Vogelmeier, et al.
Pulmonary Pharmacology & Therapeutics|October 24, 2007
Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?Staffan Edsbäcker, Per Wollmer, Olof Selroos, et al.
Drugs in R&D|September 18, 2013
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPDGabriella Gálffy, Györgyi Mezei, Gyula Németh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 3, 2016
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler dataVeronika Müller, Gabriella Gálffy, Márta Orosz, et al.
Pageof 4